Conservative treatment of upper urinary tract carcinoma in patients with imperative indications

• Published in: Minerva urologica e nefrologica = The Italian journal of urology and nephrology
• Main Authors: Proietti, Silvia, Marchioni, Michele, Eisner, Brian H, Lucianò, Roberta, Saitta, Giuseppe, Rodríguez-Socarrás, Moises E, D'orta, Carlo, Bellinzoni, Piera, Schips, Luigi, Gaboardi, Franco, Giusti, Guido
• Format: Journal Article
• Language: English
• Published: Italy 01.04.2021
• ISSN: 1827-1758
• DOI: 10.23736/S0393-2249.20.03710-8

To report our experience for endoscopic treatment of upper urinary tract carcinoma (UTUC) in patients with imperative indications for management. Retrospective data were collected for all patients who underwent endoscopic management of UTUC for imperative situations, from September 2013 to January 2019. Comorbidity was determined by using the age-adjusted Charlson comorbidity index (CCI). The primary endpoint of the study was overall survival (OS). Secondary outcomes were recurrence- free survival (RFS) rates, complication rates and global renal function. A total of 29 patients were enrolled in the study. The median age was 69.0 (IQR 63.0- 79.0) years and the median CCI was 6 (IQR 4-8). Overall, 137 endoscopic procedures were performed; 117 (85.4%) had no complication. Clavien-Dindo grade III and IV complications were 3 (2.2%) and 1 (0.7%) respectively. The median follow-up of 23 months (IQR 14-35). During the follow-up, 2 (6.9%) patients died for cause not related to cancer. Recurrence of UTUC occurred in 18 patients (61.1%). The 24-month OS was 96.4 ± 3.5% and the 24-month RFS was 31.7 ± 9.4%. Lower RFS rates were found in high grade tumor patients (22.2 ± 13.9%) compared to low grade tumor patients (35.6 ± 12.3%) (p=0.237). There was statistical difference in creatinine and eGFR values when comparing baseline to last follow-up (p=0.018 and p=0.005, respectively). Endoscopic management of UTUC in patients with imperative indications appears to be a reasonable alternative to nephroureterectomy. However, stringent endoscopic follow- up is necessary due to the high risk of disease recurrence.